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cense.Abstract Introduction: Elastography is a non-invasive medical imaging technique that detects
tumors based on their stiffness (elasticity). Strain images display the relative stiffness of lesions com-
pared with the stiffness of surrounding tissue as cancerous tumors tend to be many times stiffer than
the normal tissue, which ‘‘gives’’ under compression. An image in which different degrees of stiff-
ness show as different shades of light and dark is called an elastogram.
Purpose: To prospectively evaluate the sensitivity and speciﬁcity of the real-time sonoelastography
as compared with B-mode US for distinguishing between benign and malignant solid breast masses.
The density of the glandular breast tissue was taken in consideration in addition to the Breast Imag-
ing Reporting and Data System (BI-RADS) categories of the lesions, with biopsy results as the ref-
erence standard.
Methods: A total of 216 candidate solid lesions (123 benign and 93 malignant) in 188 patients were
examined with 2-dimensional ultrasonography, elastosonography and mammography (for 147
patients). The lesions were classiﬁed according to the density of the glandular breast tissue into
low density group (D1) and a high density group (D2) and were categorized with the BIRADS
score. Elastographic images were assigned an elasticity score of 1 to 5 (1–3, benign; 4 and 5, malig-
nant) according to the Multi-Center Team of Study and the strain ratios of the lesions were mea-
sured. Concordance between the imaging ﬁndings and histopathologic results was documented.ST University, 6 th October
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Table 1 Stavros criteria of benig
masses (2).
Criteria associated with
benign lesion
Smooth shape (rounded, oval)
Linear well deﬁned margin
Homogenous echotexture
Iso, hypoechoic
Distal/edge shadowing
Width to AP diameter P1.4
Gentle lobulation
Dilated ducts
302 M.A. Shaaban, Abo El-Ata K. AlyStatistical analysis was performed and sensitivity, speciﬁcity and positive and negative predictive
values for both elastography and conventional sonography were calculated.
Results: Elastography showed less sensitivity but higher speciﬁcity than conventional sonography
in the differentiation of benign from malignant solid lesions: B-mode sonography had sensitivity of
85.1%, speciﬁcity of 93.9%, a positive predictive value of 92.5% and a negative predictive value of
87.8%, compared with the sensitivity of 80.1%, speciﬁcity of 97.1%, a positive predictive value of
96.8% and a negative predictive value of 82.1% for elastography. Elastography was superior to B-
mode US in diagnosing solid lesions in the low density group (D1) (96.6% vs. 92.4% speciﬁcity) and
less in the dense glandular tissue (97.8% vs. 95.9% speciﬁcity).
Conclusions: Real-time sonoelastography is an useful technique for the characterization of benign
and malignant solid lesions as it increases the diagnostic speciﬁcity comparable to B-mode ultra-
sound, particularly in both ACR 1 and 2, thus reducing the false-positive rate.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Breast ultrasonography (US) has become an invaluable tool
for the detection of breast lesions: a decade ago, physicians
found that the imaging features on ultrasonographic images
could be used to classify benign and malignant solid breast
masses and thus decrease the numbers of biopsies performed
(1). US, however, is still strongly operator-dependant, and a
correct diagnosis may be sometimes difﬁcult because of the
overlapping between the features of malignant and benign
breast lesions, although they have been described (2–4) and
categorized (5). Conventional ultrasound can distinguish be-
nign from malignant breast lesions based on the appearance
of the lesion: margin irregularity, shape, echogenicity and
shadowing (2) (Table 1).
Compressibility has also been used to assess a lesion (6).
Soft benign lesions will ﬂatten more upon compression than
hard malignant ones. However, this may be subjective and
operator-dependent. Consequently, the diagnostic conﬁrma-
tion may often require image-guided biopsy procedures.
Recently, sonoelastography (SE), looking at the mechanical
properties of tissues (relative stiffness) as opposed to conven-
tional ultrasound, which looks at the backscatter of transmit-
ted ultrasound waves through tissues (7). Elastography is the
technique of imaging the hardness of soft tissue. Strain images
display the relative stiffness of lesions compared with the stiff-
ness of surrounding tissue. Stiffer areas deform less easily than
do their surroundings and are depicted as dark on strain
images, whereas softer areas deform more easily than do their
surroundings and are depicted as light. Malignant masses typ-n versus malignant breast
Criteria associated
with malignant lesion
Irregular shape
Ill deﬁned/spiculated
Heterogenous echotexture
Distorted architexture
Central shadowing
Width to AP diameter 61.4
Micro-lobulation
Microcalciﬁcationically appear dark and have high contrast with background
breast tissue during deformation. Benign masses typically ap-
pear lighter and have lower contrast with background breast
tissue during deformation (8). The interpretation criteria in
elastography consist of the qualitative parameter elasticity
score (ES) and the quantitative parameter strain ratio (SR).
Various qualitative classiﬁcations that differentiate between 3
and 5 patterns have been reported for real-time elastography
(RTE); the most frequently used one being that differentiates
ﬁve RTE patterns, where patterns 4 and 5 indicate malignant
breast lesions and patterns 1–3 indicate benign breast lesions
(9). A semiquantitative method of lesion assessment, referred
to as strain ratio measurement, has also been developed. Cal-
culation of the SR value is based on determining the average
strain measured in a lesion and comparing it to the average
strain of a similar area of fatty tissue in the adjacent breast tis-
sue. The SR reﬂects the relative stiffness of the lesion. Proba-
bility of malignancy increases as the SR value increases (10).
Tissue elasticity imaging is performed with a conventional
ultrasound probe and does not require additional equipment.
The calculation of tissue elasticity is in real-time and the resul-
tant strain image is represented in color over the conventional
B mode ultrasound. In addition, the B mode image can be dis-
played at the same time as the elastography strain image. This
method combines the added information from elastography
with the ﬂexible manipulation of a free-hand probe (11).
The aim of the study was to prospectively evaluate the sen-
sitivity and speciﬁcity of the real-time sonoelastography as
compared with B-mode US for distinguishing between benign
and malignant solid breast masses, taking into consideration
the density of the glandular breast tissue and the Breast Imag-
ing Reporting and Data System (BI-RADS) categories of the
lesions (5), with biopsy results as the reference standard.
2. Materials and methods
Two hundred forty-three patients who underwent imaging of
292 solid focal lesions were enrolled between December 2009
and June 2010. Only pathologically proved lesions, 216 in
188 patients, were included in the study. Their ages were rang-
ing between 18 and 72 years (mean age of 45 years). One hun-
dred thirty-eight lesions were palpable (63.9%) and the
remaining 78 lesions (36.1%) were nonpalpable. The inclusion
criterion was demonstration of a solid focal lesion by
ultrasound. This number represents the set of eligible cases,
Real-time ultrasound elastography: Does it improve 303after the exclusion of 16 cases because of unsatisfactory image
quality.
Histopathologic results of percutaneous or excisional
biopsy were considered the reference standard. Concordance
between the imaging and histopathologic results was docu-
mented for each lesion to minimize the chance of sampling
error.
2.1. Mammography
Mammographies were available in 147 of 188 study patients.
Mammographic examinations were performed with a dedi-
cated mammography unit Mammomat 1000 (Siemens). The re-
sults included in our report were based on the standard
craniocaudal and mediolateral oblique projections of each
breast; some patients needed cone down views with or without
markers. No mammographies were performed in 41 patients
(21.8%), for the following reasons: benign lesions and the pa-
tients’ young age (635 years) in 29 cases, 5 patients had a
mammography within less than 12 months, 2 patients had re-
fused mammography and outside ﬁlms that were not available
in 5 cases.
2.1.1. Assessment criteria
Mammographies were evaluated for the glandular density
according to the American College of Radiology (ACR) clas-
siﬁcation that identiﬁed four major groups for classifying
breast density (Kopans (12)): (1) predominantly fat; (2) fat
with some ﬁbroglandular tissue; (3) heterogeneously dense;
(4) extremely dense.
2.2. US technique
After the clinical examination (inspection, palpation), all 188
patients underwent ultrasonography using a high-end US de-
vice (HITACHI EUB-7500) with the integrated elastography
software and a linear transducer ranging from 7 to 12 MHz,
depending on lesion depth and breast thickness. On US, both
breasts were scanned as well as the area of the expected abnor-
mality. The patients were put in a supine position with the ipsi-
lateral arm behind the head, and then rolled to the
contralateral posterior oblique position (to ﬂatten the breast
tissue over chest wall and maximizing the high frequency probe
scanning characteristics). The protocol included scanning in
both transverse and longitudinal real-time imaging, examining
the whole breasts circularly and then targeting on the region of
complaint. The lesions were described according to number,
location, greatest diameter, shape, orientation, echogenicity,
echo-texture, margin, acoustic transmission and the presence
of calciﬁcation.
Following conventional US B mode scanning, Power
Doppler study US was done to majority of the patients. The
scanning plan was selected for optimal visualization of vascu-
larity. Tissue velocities were encoded in red and blue depend-
ing on direction and superimposed on the lesion.
2.2.1. Assessment criteria
Lesion characterization on the B-mode images was done using
the BI-RADS criteria of the American College of Radiology
(5). In absence of mammography, the US scans were also eval-
uated using the American College of Radiology criteria and––
analogous to the mammography densities––categories I–IVwere assigned according to the sonographic density of the
breast tissue. Patients with indices of I and II were assigned
to group D1, those with III or IV to group D2. Lesions with
BI-RADS categories II and III were classiﬁed as benign and
those with BI-RADS IV and V as malignant.
In Power Doppler US study, the vascularity of the lesions
and distribution were analyzed and then were classiﬁed into
two categories: avascular and vascular either hypovascular
(less than 20% color ﬂow) or hypervascular (more than 20%
color ﬂow).
2.3. Elastographic method
After B-mode US detection of the lesion of interest, the patient
remains in the supine position, and a stabilizer device is
mounted on the probe to hold a homogeneous pressure on a
wider area of the skin’s surface by minimizing lateral move-
ments of the probe. Then the dual elastographic program
starts, with the US monitor showing in real time the B-mode
US image of the lesion on the right side and the same image
with color-coded elasticity features superimposed on the left
side and motion images are obtained by applying a light con-
stant pressure with the probe in contact with the skin perpen-
dicular to the chest wall. In order to obtain correct
elastographic images, attention must be paid to the deﬁnition
of the ROI, which has to be sufﬁciently wide to include enough
breast tissue surrounding the lesion so that data about the
average strain of the tissue inside the region are available.
The ROI usually must extend from the subcutaneous fat at
the top to the anterior proﬁle of the pectoral muscle at the bot-
tom, with lateral borders set more than 5 mm from the lesion’s
boundary. The exam is correctly performed checking the 1–5
LED scale that appears laterally to the right of the elasto-
graphic image that is indicative of proportionality between
pressure and tissue strain. The color-coded image must be con-
sistently overlapped with the B-mode US image, with a smooth
appearance and without color ﬂashes. The elasticity images are
obtained according to a 256-color scale ranging from red,
indicative of the softest tissues that show the greatest strain,
to blue for the hardest components that do not exhibit any
strain, with green corresponding to the average strain observed
in the ROI. Strain imaging allowed analysis of the strain ratio
values that were also calculated. The examination took
approximately 10–15 min.
2.3.1. Assessment criteria
To classify elastographic images, the 5-score system proposed
by Ueno and co-workers (13) was considered; however, a slight
adjustment of Ueno scoring descriptors was undertaken
according to the panel assessment of an Italian Multi-Centric
Team of Study for Sonoelastography Evaluation (14). It differs
mainly for the score 1 lesions, which exhibit a typical three-
layer feature (blue–green–red from the surface to the bottom)
usually indicative of cystic lesions.
In our classiﬁcation, score 2 is a benign-like lesion almost
entirely green with random blue points. A score 3 is a lesion
predominantly green showing some blue spots, consistent with
benignity. Score 4 is an almost entirely blue lesion with mini-
mal green points at the periphery, suspect for malignancy.
Score 5 is the same as in the Ueno classiﬁcation, with an en-
tirely blue lesion surrounded by a blue halo, consistent with
malignancy (Fig. 1).
Fig. 1 Sonoelastographic classiﬁcation by the Italian Multi-Center Team of Study (14).
Table 2 Relationships between US and SE scores in 216
breast lesions.
US scores (BI-RADS) Sonoelastographic scores Total
2 3 4 5
2 38 17 1 Nil 56
3 14 35 9 1 59
4 Nil Nil 51 26 77
5 Nil Nil 9 15 24
Total 52 52 70 42 216
Table 3 Histologic diagnosis in 216 solid breast lesions.
Pathologic diagnosis No. of cases Percent
Malignant lesions 93 33.8
-Ductal invasive carcinoma 71 32.9
-Lobular invasive carcinoma 13 6
-Mucinous carcinoma 1 0.5
-Tubular carcinoma 2 0.9
-DCIS 6 2.8
Benign lesions 123 66.2
-Fibroadenoma 101 46.8
-Fat necrosis 9 4.2
-Itraductal papilloma 4 1.9
-Fibrocytic changes 3 1.4
-Atypical hyperplasia 1 0.5
-Intramammary lymph node 2 0.9
-Hamartoma 2 0.9
-Tubular adenoma 1 0.5
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interest and a comparable region of interest placed in the lat-
eral fatty tissue. According to Cohn (15), we assumed a mean
strain ratio of 1.83 for benign lesions and 8.38 for malignant
lesions with a cutoff point of 3.05.
According to both RTE patterns and SR measurement, the
lesions were categorized with the BI-RADS score into benign
and malignant. Among the 216 solid breast lesions, the rela-
tionship between US and SE scores is shown in Table 2.
3. Results
Histologic examinations yielded 93 malignant (43%) and 123
benign lesions (57%). The mean tumor diameter was 2.1 cm
(range 0.7–3.5 cm). The histologic diagnosis of all 216 lesions
is listed in Table 3.
3.1. Grouping according to breast density
Mammographies were available for 147 of our 188 patients
with histologically proven focal lesions (78.2%). In these 147
patients, the glandular tissue was assigned a density index of
ACR 1 or 2, (involuted, partially involuted glandular tissue)
in 87 (59.2%) cases based on mammography and in 19 of
the remaining 41 cases (46.3%) based on B-mode US with a
total of 106 patients (56.4%) with 125 lesions (58%). These le-
sions were set as low density group (D1) while the 91 lesions
(42%) in the 82 patients with prominent breast density
(ACR 3 and 4) were set as high group density (D2).
3.2. B-mode US
Evaluation of the B-mode images correctly diagnosed 108 of
123 benign lesions, whereas 15 benign lesions were assigned
BI-RADS 4 or 5. Reliably identiﬁed were 86 of 93 malignant
lesions, whereas the remaining 7 lesions were classiﬁed as BI-
RADS 2 or 3. B-mode US thus had a sensitivity of 85.1%
and a speciﬁcity of 93.9% (Table 4).For lesions in patients with pronounced involution of glan-
dular breast tissue (group D1), B-mode US reliably diagnosed
51 of the 56 malignant lesions and 61 of the 69 benign lesions;
while in group D2, 35 malignant lesions were identiﬁed of the
37 and 47 of the 54 benign ones. Thus a lower breast tissue
density is associated with a lower speciﬁcity (92.4%) and in-
creased sensitivity (86.4%) compared to group D2 (Table 5).
Table 4 Sensitivity, speciﬁcity, positive and negative predic-
tive values of B-mode ultrasound and elastography.
B-mode (%) Elastography (%)
Sensitivity 85 80
Speciﬁcity 94 97
Positive predictive value 92.5 97
Negative predictive value 88 82
Table 5 Sensitivity, speciﬁcity, positive and negative predic-
tive values in relation to density indices I–II (group D1) and
III–IV (group D2).
B-mode Elastography
D1 (%) D2 (%) D1 (%) D2 (%)
Sensitivity 86 83 82 78
Speciﬁcity 92 96 97 98
Positive predictive value 91 95 96 97
Negative predictive value 88 87 83 81.5
15
101
7
86
34
0
20
40
60
80
100
120
140
Number of 
lesions
Benign Malignan
Histopathology
Fig. 2 Bar graph demonstrating the distribution of ultrasound an
Fig. 3 A 47-year-old lady having her Routine Screening Mammogra
Doppler (A) revealed abnormal internal vascularity. Elastography (B) r
and the surrounding tissue. It was categorized as BIRADS 4c. Biopsy
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101 of the 123 benign lesions were diagnosed correctly as well
as 90 of the 93 malignant tumors. Elastography had a sensitiv-
ity of 80.1% and a speciﬁcity of 97.1% (Table 4).
For 125 patients with a density index of ACR 1 or 2 (group
D1), elastography correctly diagnosed 57 out of 69 benign
lesions and 54 of the 56 malignant lesions. This resulted in a
sensitivity and speciﬁcity of elastography in group D1 of
81.8% and 96.6%, respectively, as opposed to 78.3% and
97.8% in group D2 (Table 5). The distribution of ultrasound
and elastographic classiﬁcations for malignant and benign
lesions is represented in Fig. 2.
Figs. 3 and 4 are lesions of elastographic score 4 and high
strain ratio values; while Figs. 5–7 are for lesions yielding
scores 2 or 3 with low SR values.
4. Discussion
The advances in ultrasound technology over the past two dec-
ades have transformed this diagnostic modality into at
US benign Elastography
Malignant
US benign Elastography
benign
US Malignant Elastography
Malignant
d elastographic classiﬁcations for malignant and benign lesions.
m. US revealed a micro lobulated hypoechoic solid lesion. Color
evealed score 4 and the SR yielded the value 5.72 between the mass
demonstrated invasive duct carcinoma.
Fig. 4 A 54-year-old lady with a right breast palpable lump. Mammogram (with breast density of ACR 3) revealed a well deﬁned nodule
(A). US revealed it as a well deﬁned hypoechoic solid lesion presenting a single angulation and was categorized as BIRADS 3.
Elastography (B) revealed score 4 with a SR of 4.42 and consequently was categorized as BIRADS 4 a. Biopsy conﬁrmed the elastographic
classiﬁcation as being mucinous carcinoma.
Fig. 5 A 40 year old woman complaining of bilateral mastalgia. Mammogram (with breast density of ACR 2) revealed a rather deﬁned
oval lesion with a lucent halo in the UOQ of the left breast (A). US (B) demonstrated an underlying focal lesion of heterogenous
ﬁbroglandular like echogenicity. Eastographic score 2 suggested its benign nature (C). Biopsy revealed it to be a hamartoma.
306 M.A. Shaaban, Abo El-Ata K. Alydiagnostic tool that allows the exclusion of malignant breast
tumors and identiﬁcation of deﬁnitely benign lesions. This is
why ultrasound has been referred to as the stethoscope of
the future (16). Real-time elastography, a noninvasive method
for revealing the physical properties of a tissue, has been devel-
oped as an alternative to breast biopsy (9). The elastographic
information is immediately available and superimposed in col-
or on the B-mode image. Sonoelastography is, therefore, not
more time consuming than conventional breast US (17).The ability of SE to evaluate the mechanical properties of
different tissues is an useful diagnostic tool that provides fur-
ther information about breast lesions in addition to the well-
known morphologic parameters such as shape, orientation,
margins, internal structure and the presence of calciﬁcations.
These additional ﬁndings may be very useful in distinguishing
malignant from benign solid lesions; as well, the stiffness of a
mass as perceived at palpation plays an important role in the
clinical assessment (18). Changes in elastic properties between
Fig. 6 A 29 year-old-lady doing US follow up (A) for a palpable left retroareolar intraductal heterogeneous hypoechoic solid lesion with
high vascularity on color Doppler application (B) (classiﬁed as BIRADS 3). Elastography revealed score 3 (benign) (C). By Biopsy, it was
proved to be an intraductal papilloma.
Fig. 7 US of a 26-year-old woman with a right breast palpable lump revealed a well deﬁned lobulated hypoechoic solid mass with
vascularity on color Doppler demonstration (A). Ultrasound elastography (B) revealed score: 2, and a strain ratio value of 2.11 (benign)
between the mass and the surrounding tissue. By Biopsy, it was proved to be a ﬁbroadenoma.
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previous papers (19,20), assessing that neoplastic lumps are
signiﬁcantly harder than ﬁbroadenomas. In addition, malig-
nant lesions tend to be larger on US strain images than on cor-
responding B-mode US images, perhaps because of the
desmoplastic reaction commonly associated with malignancy
(8,13,21–25). The changes in contrast with deformation can
only be appreciated in a sequence of images. The appearanceof masses on strain images and lesion size discrepancies be-
tween B-mode and strain images is a promising tool for distin-
guishing benign from malignant lesions.
In our work, elastographic images were assigned an elastic-
ity score of 1 to 5 (1–3, benign; 4 and 5, malignant) according
to the Multi-Center Team of Study – Locatelli et al. – (14). For
SR measurement, we utilized Cohn’s (15) results: the benign le-
sions produced a mean strain ratio of 1.83 while malignant
308 M.A. Shaaban, Abo El-Ata K. Alylesions produced a mean strain ratio of 8.38 using a cutoff
point of 3.05. As in several studies, elastography showed less
sensitivity but higher speciﬁcity than conventional sonogra-
phy: we obtained B-mode sonography sensitivity of 85.1%,
speciﬁcity of 93.9%, a positive predictive value of 92.5% and
a negative predictive value of 87.8%, compared with a sensitiv-
ity of 80.1%, a speciﬁcity of 97.1%, a positive predictive value
of 96.8% and a negative predictive value of 82.1% for
elastography.
These results agreed with those of the other studies based
on elasticity score as Navarro et al. (26) who stated that
B-mode sonography had a sensitivity of 96.6%, a speciﬁcity
of 76.9%, a positive predictive value of 79.2% and a negative
predictive value of 96.2%, compared with a sensitivity of
69.5%, a speciﬁcity of 83.1%, a positive predictive value of
78.9%, and a negative predictive value of 75.0% for elastogra-
phy. For Thomas et al. (17), sensitivity and speciﬁcity in the
differentiation of benign and malignant lesions were 94%
and 83% respectively for B-mode US while Elastography
had a sensitivity of 82% and a speciﬁcity of 87%; while for
Leong et al. (27) sensitivity and speciﬁcity were 88.5% and
42.9%, respectively, for conventional ultrasound, 100% and
73.8%, respectively, for elastography, and 88.5% and 78.6%,
respectively, for combined imaging. Holst et al. (28) found in
elastography a sensitivity of 77.6% and 79.6% and a speciﬁcity
of 91.5% and 84.7% for two observers, respectively; and for
B-mode ultrasound a sensitivity of 91.8% and a speciﬁcity of
78%.
In Cohn’s (15) study for strain ratio evaluation, when the
researchers used a cutoff point of 3.05, ultrasound elastogra-
phy had 92.4% sensitivity, 91.1% speciﬁcity, and 91.4%
accuracy. The sensitivity was higher than the ﬁve-point scoring
system, the study authors said. Comparably Zhao et al. (29)
stated that the strain ratios between benign lesion
(2.26 ± 1.39) and malignancy (6.95 ± 4.08) were signiﬁcantly
different. The sensitivity, speciﬁcity and accuracy of 2-dimen-
sional ultrasonography and strain ratio for breast cancer
detection was 81.58%, 80.28%, 80.73% and 86.84%,
88.73%, 88.07% respectively. The rate of diagnostic sensitivity
and accuracy was increased to 97.37% and 93.58% respec-
tively by a combination of 2-dimensional ultrasonography
and strain ratio measurement.
Our study emphasized Destounis’ results that demonstrated
the efﬁcacy of elastography in identifying cancerous lesions
being less effective at identifying benign lesions as well as Eliz-
abeth Wende’s who found that the technique agreed with B-
mode ultrasound on 97% of cancers but elastography was only
able to correctly point out 79% of benign lesions (30) com-
pared to 87.8% and 82.1% respectively in our study.
For us, elastography was superior to B-mode US in diag-
nosing solid lesions in lipomatous involution (96.6% vs.
92.4% speciﬁcity) and less signiﬁcantly in the dense glandular
tissue (97.8% vs. 95.9% speciﬁcity); compared to other papers
where elastography was superior to B-mode US in diagnosing
Breast in lipomatous involution (80% vs. 69% speciﬁcity) (15)
or elastography found the highest speciﬁcity of 100% in pa-
tients with dense breast tissue (28).
4.1. Limitations
Patient movement, respiratory motion, and slight changes in
position are potential sources of error when performing ultra-sound in humans: in elastography, errors in calculating elastic-
ities would primarily affect ‘‘harder’’ tissues and make them
appear ‘‘softer’’ and thus give rise to false negative ﬁndings.
A reported limitation is in evaluating focal lesions located at
a depth of more than 1 cm because of incomplete coloring.
Further standardization of elastography is required with
regard to the amount of compression applied, patient position-
ing, and subjective assessment of elastograms in the course of
the examination (22).
According to univariate analysis, smaller lesion size
(P= .001), shallower lesion depth (P= .005), less breast thick-
ness where the lesion was located (P< .0001), and benign path-
ologic ﬁnding (P= .004) were signiﬁcantly associated with
higher image quality. There was no correlation of image quality
with age (P= .213), BMI (P= .191), mammographic density
(P= .091), or distance from the nipple (P= .100). Multivari-
able analysis showed that breast thickness at the location of
target lesions was the most important factor inﬂuencing elastic-
ity image quality (P= .001). There were signiﬁcant differences
in sensitivity between higher-quality and lower-quality images
(87.0% vs 56.8%, respectively; P= .015) in the differentiation
of benign from malignant masses (31).5. Conclusions
In summary, real-time sonoelastography is an useful technique
for the characterization of benign and malignant solid lesions
as it increases the diagnostic speciﬁcity comparable to B-mode
ultrasound, particularly in both ACR 1 and 2, thus reducing
the false-positive rate.References
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